4DMT Advances 4D-710 to Phase 2 with Additional Funding and Support from the Cystic Fibrosis Foundation
Источник:
Nasdaq GlobeNewswire
/
13 окт 2025 08:00:00 America/New_York
N/A
Опубликовать